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Introduction
Depression is prevalent among people living 
with HIV (PLWH). In South Africa, where the 
greatest number of PLWH reside worldwide, 
rates of depression have been found to be 41 per-
cent among PLWH (Freeman et al., 2008). 
Depression is associated with compromised 
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immune functioning and accelerated disease 
progression among PLWH (Leserman et al., 
1999) and sub-optimal antiretroviral therapy 
(ART) adherence (Gonzalez et al., 2011; 
Nakimuli-Mpungu et al., 2012; Uthman et al., 
2014). ART non-adherence in South Africa, and 
other low- and middle-income countries 
(LMICs), has serious consequences as it may 
lead to drug resistance in a setting where limited 
ART regimens are available.
Addressing depression in HIV care in South 
Africa has potential to improve HIV treatment 
and prevention; however, it is estimated that 
only one in four patients with a psychiatric dis-
order receive appropriate treatment (Seedat 
et al., 2008). This is in part due to lack of access 
to specialized mental health providers in South 
Africa. Psychologists and psychiatrists are in 
short supply with 0.28 psychiatrists and 0.32 
psychologists per 100,000 population working 
in the public health sector (Lund et al., 2010). 
Although psychotropic medication is typically 
available in primary care, resources for evi-
dence-based psychotherapeutic interventions 
are scarce (Lund et al., 2010). In a resource-
constrained context, such as South Africa, task-
sharing, whereby non-mental health specialists 
provide mental health services under the super-
vision of specialists, may be the most feasible 
approach for delivering mental health services 
in primary care (Saraceno et al., 2007).
An effective and feasible therapy model for 
depression that could be integrated into primary 
HIV care in South Africa is needed. Cognitive 
behavioral therapy (CBT) is a therapy model 
with a strong empirical base for the treatment of 
depression. Research on the effectiveness of 
CBT for depression in PLWH has shown promis-
ing results (Safren et al., 2009, 2012; Spies et al., 
2013). In the United States, an intervention that 
integrates CBT for depression with a cognitive 
behavioral approach to adherence counseling 
(cognitive behavioral therapy intervention for 
adherence and depression (CBT-AD)) has been 
found to be effective in improving adherence and 
reducing depression in PLWH and on the United 
States–Mexico border with Mexican patients 
(Safren et al., 2004, 2009, 2012; Simoni et al., 
2013). Furthermore, there is prior evidence that 
CBT can be delivered by non-mental health spe-
cialists (Malik et al., 2009; Nicholas, 2014; 
Rahman et al., 2008), including in sub-Saharan 
Africa (Bere et al., 2018).
Based on previous quantitative (Andersen, 
2009) and qualitative studies (Andersen et al., 
2015) conducted by our research team in peri-
urban areas outside Cape Town, we developed 
an intervention based on CBT-AD for delivery 
using a task-sharing model (i.e. with clinical 
nurse practitioners) called Ziphamandla 
(Empower Yourself). This pilot study was a first 
step to adapting and examining the applicability 
and usefulness of Ziphamandla in treating 
adherence and depression in ART users in South 
Africa. The aims of this study were to assess if 
Ziphamandla was (1) feasible and acceptable to 
patients and providers (measured by patient 
retention and provider fidelity to intervention 
delivery) and (2) associated with improvements 
in depressive symptoms, functioning, and ART 
adherence.
Method
Setting
The study was conducted in Khayelitsha, one of 
the largest peri-urban areas in the Western Cape 
(~400,000 people), where approximately 20 per-
cent of people are HIV-positive (Strategic 
Development Information and GIS Department, 
2011). Recruitment and treatment took place at 
two of the busiest primary HIV care clinics in the 
area, referred to here as Site 1 and Site 2.
Study design and procedures
Adaptation of CBT-AD. A South African team 
consisting of clinical psychologists, psychia-
trists, and a psychiatric nurse, with input and 
support from the US team who developed CBT-
AD, planned for study design and the adapta-
tion of CBT-AD to the South Africa context 
(Safren et al., 2009, 2012). The three main con-
siderations were (1) feasibility of rolling out the 
intervention, (2) the cultural relevance and 
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comprehensibility of the treatment content, and 
(3) the training schedule and materials for the 
interventionists.
Feasibility. To ensure feasibility of roll-out, two 
important decisions were made with regard to 
study design: (1) location of treatment delivery 
needed to be primary HIV clinics to ensure 
accessibility for patients in Khayelitsha and (2) 
the chosen cadre of interventionist needed to 
represent staff present at the clinics (i.e. clinical 
nurse practitioners). Furthermore, three major 
decisions were made to accommodate delivery 
in primary health care using a task-sharing 
model: first, the number of treatment sessions 
was reduced to a maximum of eight and 
included a range of six to eight sessions to allow 
for exploration of optimal session length. Sec-
ond, the cognitive restructuring module was 
removed. The team ultimately decided that the 
time needed to train and supervise non-special-
ists in this technique reduced long-term feasi-
bility of rolling out this intervention in primary 
care, which was a primary consideration. Prior 
research has found behavioral activation to be 
as effective as the full CBT package including 
cognitive restructuring in the treatment of 
depression (Jacobson et al., 2000), thus the 
team felt confident that the treatment protocol 
would be as valuable without the inclusion of 
the cognitive restructuring module.
Third, the decision was made to tailor the 
order of the treatment modules to the individual 
needs of each patient. Each patient’s particular 
situation dictated the order in which the prob-
lem-solving, behavioral activation and relaxa-
tion modules were administered following the 
Life Steps adherence intervention session.
Training schedule and materials. The team recog-
nized the importance of an adapted, structured, 
easy-to-use manual for intervention delivery, 
with a checklist of session content for the inter-
ventionists to use as a guide throughout each 
session.
Cultural relevance/comprehensibility of the treatment 
content. The terminology used in the manual was 
modified to make it more user-friendly to non-
mental health specialists. Examples used in the 
original intervention were culture-specific to the 
United States and were replaced with items cul-
turally relevant to South Africa. For example, 
items such as “snow shoeing” were removed 
from the activity list and replaced with “hair 
braiding.” All worksheets and patient forms were 
translated into isiXhosa. Specific cultural adapta-
tions and modifications are listed in Appendix 1.
Training and supervision. Training occurred once 
a week for 4 hours. After 88 hours of training, 
the interventionists underwent an evaluation to 
determine their readiness to begin administering 
treatment. This was assessed by a written test of 
the treatment content and a role-play of a ran-
dom session. The interventionists were required 
to score above 80 percent on the written test to 
be deemed ready to begin administering treat-
ment. Supervision occurred once a week in two 
separate 2-hour sessions. The morning sessions 
were spent reviewing and giving feedback on 
therapy sessions that had taken place throughout 
the week and setting goals for the upcoming 
therapy sessions. The afternoon sessions were 
spent reviewing the treatment content for the 
next therapy sessions (i.e. providing ongoing 
training on the intervention).
Participants. Eligibility criteria for this study con-
sisted of being an adult (18+ years), being fluent 
in either isiXhosa or English, meeting diagnostic 
criteria for major depressive disorder (MDD) as 
assessed by the Mini International Neuropsychi-
atric Interview 6.0 (MINI), being HIV-positive, 
and using ART. Moreover, it was a requirement 
that the participants had obtained knowledge of 
their HIV-positive status at least 6 months prior to 
the study assessment date to ensure appropriate 
MDD diagnosis. Participants were excluded from 
the study if they were actively suicidal or psy-
chotic or if they had an uncontrolled neurological 
problem. Additional exclusion criteria included 
(1) having been initiated on or had their dose of 
psychotropic medication altered within the past 
3 months, (2) currently receiving psychotherapy 
for depression, or (3) having previously received 
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CBT. None of the patients who met criteria for 
MDD on the MINI met these exclusion criteria. A 
total of 14 participants, 7 from each of the two 
sites, were recruited for the study from Septem-
ber 2011 to June 2012.
Recruitment. A recruitment nurse conducted 
screenings of patients in the designated HIV 
treatment waiting areas at Sites 1 and 2. Patients 
were identified based on the day’s list of patients 
waiting to receive their ART medication refills. 
Clinic staff had been briefed on the study and 
they referred patients to the study. At Site 2, a 
screening program, which had been imple-
mented by a non-governmental organization 
(Breuer et al., 2012, 2014), was also used for 
referrals. The research assistant screened 
patients who consented to participate using the 
Center for Epidemiological Studies Depression 
Scale (CES-D). Patients who screened positive 
(CES-D ⩾20) were scheduled for an assess-
ment interview with the study psychologist and 
the research assistant.
Procedure. Individuals who met study eligibility 
criteria and were interested in participating in the 
study provided informed consent and then a base-
line assessment was conducted (measures listed 
below). The first Ziphamandla treatment session 
was scheduled for the following week at their 
clinic. All treatment sessions were audio recorded 
with the consent of the participants. Assessments 
of self-reported depressive symptoms and objec-
tive ART adherence were conducted weekly prior 
to the start of each therapy session. Clinician 
assessments were re-administered at the end of 
treatment and at 3-month follow up. The study 
was approved by the University of Cape Town 
Human Research Ethics Committee.
Self-report assessments
Self-report assessments were administered in 
isiXhosa by a bilingual study research assistant 
and included the following.
CES-D. The CES-D is a 20-item self-report 
questionnaire of depressive symptoms, 
including sadness, sleep disturbance, and loss 
of appetite. Each item is scored from 0 to 3. 
There are four positive items that are reverse 
coded for calculating the total score. The 
CES-D has been shown to have excellent valid-
ity and reliability in previous research in South 
Africa (Pretorius, 1991), and the scale has been 
used in studies of PLWH in South Africa (Myer 
et al., 2008). When the CES-D was validated 
against the MINI in a study of PLWH in South 
Africa, a cut-off of 20 in detecting MDD yielded 
a sensitivity of 79 percent and specificity of 
61 percent (Myer et al., 2008).
Sheehan Disability Scale. The 3-item Sheehan Dis-
ability Scale (SDS) assesses impairment in three 
domains (work, family life, and social life). The 
three domains are rated on a Likert scale from 0 
to 10, with higher scores indicating more impair-
ment. The SDS has demonstrated good reliability 
and validity in assessing psychiatric impairment 
including impairment caused by depression 
(Leon et al., 1997). It has previously been used in 
studies conducted among PLWH in South Africa 
(Andersen, 2009; Olley et al., 2004).
The CES-D and SDS were translated using 
Brislin’s (1970) classic back-translation model. 
Back-translation is a well-known method used 
to maintain equivalence when translating source 
language to target language (Behling & Law, 
2000). The measures were translated and back 
translated into isiXhosa, checked by a third 
bilingual translator, and then administered in 
isiXhosa.
Clinician-administered assessments
A study psychologist administered the clinician 
assessments in English with the support of the 
research assistant for translation into isiXhosa 
when necessary. These included the following.
MINI. Diagnostic evaluations were conducted 
using the Mini International Diagnostic Inter-
view 6.0 (MINI). The MINI is a structured 
diagnostic interview that elicits all the symptom 
criteria specified in the Diagnostic and Statisti-
cal Manual of Mental Disorders (4th ed.; 
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DSM-IV) and International Classification of 
Diseases–10th Revision (ICD-10) for 19 Axis I 
and II disorders and suicidality (Sheehan et al., 
1998). It was created for use in international 
clinical settings and research. The MINI dem-
onstrates good reliability and validity. It has 
been validated against the Structured Clinical 
Interview for DSM diagnosis (SCID-P) and the 
Composite International Diagnostic Interview 
for ICD-10 (Sheehan et al., 1998).
Hamilton Depression Scale. The Hamilton 
Depression Scale (HAM-D) is a 17-item clini-
cian-administered assessment of depression 
severity (Hamilton, 1959). Each item is scored 
from 0 to 4, with the total score being an aggre-
gate of all item scores. Higher scores indicate 
greater severity. The HAM-D is the most widely 
used measure of treatment outcome in MDD 
studies and has been shown to have satisfactory 
psychometric properties in the general popula-
tion (Bagby et al., 2004). The HAM-D has been 
used in prior trials in South Africa, with a cut-
off of ⩽6 indicating depression remission (e.g. 
Kennedy and Emsley, 2006).
ARV adherence
Adherence was monitored during treatment 
with real-time medication monitoring, (i.e. 
Wisepill technology; Haberer et al., 2010). 
Wisepill uses Internet and cell-phone-based 
technology to allow investigators to monitor in 
real time when a pillbox, containing partici-
pants’ ART medication, has been opened. 
Adherence scores were calculated by dividing 
the number of times the pillbox was opened 
during each week by the number of doses pre-
scribed for the week. A dose was considered 
missed if it was not taken within the 2-hour 
window of the prearranged dose time. A 2-week 
baseline period was established to obtain adher-
ence data for each participant before the inter-
vention was administered. In addition to 
determining weekly adherence scores, the per-
centage of the sample that maintained ART 
adherence ⩾80 percent throughout the study 
period was assessed given recent evidence of 
the clinical importance of treatment interrup-
tions for viral suppression (Parienti et al., 2008).
Therapist fidelity rating procedure
Upon completion of all treatment sessions, one 
session from each participant and seven ses-
sions by each nurse were randomly selected and 
translated into English by a bilingual translator 
(14 of the 90 session recordings; 15.6%). Two 
study psychologists independently rated fidel-
ity and quality of the treatment administration 
using two rating scales drawn from the original 
CBT-AD studies (Safren et al., 2009, 2012). 
The one rating scale focuses on nine generic 
CBT strategies, which should occur in every 
session. These include collaboratively setting 
the agenda, reviewing medication adherence, 
and assigning homework. A Likert scale (0 to 6) 
is used to score each item. The other rating 
scale focuses on the session-specific content. 
For example, in the first behavioral activation 
session, items such as “Goes through the posi-
tive events checklist” were rated from 0 to 2 to 
indicate did not complete (0), completed but not 
satisfactorily (1), and completed satisfactorily 
(2). Fidelity ratings were recorded as a percent-
age of components completed for each session 
(two separate percentages for generic CBT 
strategies and session-specific content).
Treatment attendance
Therapy sessions were scheduled weekly. The 
length of treatment was tailored to patient needs 
(ranging from six to eight sessions). Based on 
participants’ progress, the study nurses and psy-
chologists decided on the number of sessions 
each participant warranted. Treatment comple-
tion was defined as greater than five treatment 
sessions attended.
Overview of statistical analyses
Generalized linear mixed models (GLMM; 
GENLINMIXED) in SPSS (version 21) were 
used for all longitudinal analyses. Change in 
clinician-rated depressive symptoms (HAM-D) 
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was assessed from baseline to the 3-month fol-
low up (i.e. three time points). Change in self-
reported depressive symptoms (CES-D) was 
assessed from baseline to the 3-month follow up 
and weekly at each therapy session (up to 10 
assessments total). Wisepill adherence assess-
ments were only available from baseline to post-
treatment (weekly data at each therapy session; 
up to eight assessments total). GLMM has an 
advantage in which it can accommodate depend-
ent variables that are non-normally distributed 
and can accommodate missing data. For each 
analysis, the appropriate model was selected 
based on the distribution of the main outcome 
variable (e.g. linear or gamma for positively 
skewed outcomes). In all models, the main 
effect of time was entered as a fixed effect. Due 
to the small sample size, no random effects or 
intercepts were included in the model. Degrees 
of freedom were determined via the Satterthwaite 
approximation, which is preferred over the 
residual method when sample size is small, as in 
this study. The autoregressive (AR-1) covari-
ance structure was used to account for the dis-
tinct time intervals of assessments. All models 
employed robust estimation (which handles vio-
lations of model assumptions). Finally, as a met-
ric of effect size, Cohen’s d was computed for 
each outcome within subjects from baseline to 
the last assessment time point (3-month follow 
up for all outcomes with the exception of 
Wisepill adherence), accounting for the correla-
tion between means at the two time points.
Results
Participant demographics
All participants identified their ethnic origin as 
Xhosa (the second largest tribal group in South 
Africa). In all, 13 of the participants were 
female and 1 was male. Participants ranged in 
age from 28 to 59 years. See Table 1 for demo-
graphic information.
Treatment attendance
In all, 12 of the 14 patients completed the 
Ziphamandla treatment (i.e. >5 treatment 
sessions). Three-month follow-up data were 
obtained from 11 of the 12 participants who 
completed treatment and from one of the two 
participants who discontinued treatment.
Therapist fidelity
Across both raters for all sessions reviewed, a 
mean of 54 percent of generic CBT elements 
were addressed and 63 percent of session-spe-
cific components (percentages are the propor-
tion of the intervention content that was 
addressed for both general CBT elements and 
session-specific components). Agreement 
between raters was assessed based on each rat-
ing that was within 10 percent of each other for 
the two raters (examining the session-specific 
content and more general CBT ratings sepa-
rately). For the generic CBT ratings, the raters 
were in agreement for 11 out of 14 sessions 
(78.6%). For the session-specific ratings, the 
raters were in agreement for 9 out of the 14 ses-
sions (64.3%).
CES-D
A generalized mixed model was tested with 
CES-D from baseline to the 3-month follow up 
(i.e. 3 months after completion of treatment) as 
the main outcome (including weekly CES-D 
assessments; up to 10 time points total). Self-
reported depression scores significantly 
decreased over time (γ = −0.18, standard error 
(SE) = 0.03, 95% confidence interval 
(CI) = [−0.25, −0.11], t(41) = −6.08, p < .0001), 
from baseline (M = 40.9, standard deviation 
(SD) = 8.45) to the 3-month follow up 
(M = 6.58, SD = 7.61), with a very large effect 
size (Cohen’s d = 3.8).
HAM-D
A generalized mixed model was tested with 
HAM-D from baseline to the 3-month follow 
up as the main outcome (three time points total). 
Clinician-rated depression scores significantly 
decreased over time (γ = −0.71, SE = 0.18, 95% 
CI [−1.15, −0.28], t(17) = −3.89, p < .01) from 
baseline (M = 26.4, SD = 5.5) to the 3-month 
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follow up (M = 5.8, SD = 5.8), with a very large 
effect size (Cohen’s d = 2.5).
Sheehan disability
A generalized mixed model was tested examining 
Sheehan scores at baseline to the 3-month follow 
up as the main outcome (three time points total). 
There was a significant decrease in functional 
impairment over time (γ = −35.6, SE = 3.35, 95% 
CI [−42.49, −28.63], t(21) = −10.60, p < .0001) 
from baseline (M = 76.50, SD = 22.17) to the 
3-month follow up (M = 6.08, SD = 14.29), with 
a very large effect size (Cohen’s d = 2.94).
Wisepill adherence
Wisepill adherence was captured from baseline to 
post-treatment (up to 8 time points total). 
Adherence remained stable over the course of the 
study period (γ = 0.03, SE = 0.07, 95% CI [−0.11, 
0.17], t(76) = −0.45, p = .65; Cohen’s d = 0.1). Of 
those who completed treatment (n = 12), 67 per-
cent (n = 8) maintained ART adherence ⩾80 per-
cent for all assessments.
See Figure 1 for a depiction of results.
Discussion
This study is a first step in adapting and evalu-
ating CBT-AD among PLWH in South Africa 
using a task-sharing approach (Ziphamandla). 
Several formative steps were accomplished in 
this study. First, the Ziphamandla intervention 
was acceptable to patients as evidenced by 
patient retention. Second, the implementation 
of the Ziphamandla intervention was feasible as 
measured by patient retention and provider 
fidelity to intervention delivery. These findings 
are consistent with similar task-sharing psycho-
therapy implementation studies conducted in 
other LMICs (Rahman et al., 2008). The third 
formative step that was accomplished in this 
study was the collection of preliminary data that 
supports the association of the Ziphamandla 
intervention with improvements in depressive 
symptoms and functioning among PLWH. 
These results are consistent with studies on 
CBT-AD conducted elsewhere (Safren et al., 
2009, 2012; Simoni et al., 2013).
Regarding adherence, of those who com-
pleted treatment (n = 12), 67 percent maintained 
optimal ART adherence (⩾80%) throughout the 
study period. However, we did not find signifi-
cant improvements in ART adherence follow-
ing treatment. Study inclusion criteria were 
based upon depressive symptoms, not ART 
non-adherence, and as such, there may have not 
been sufficient variability in ART non-adher-
ence at baseline to detect a meaningful change 
in ART adherence over an 8-week period. 
Figure 1 shows that the most pronounced 
improvements in adherence were from baseline 
to week 4, immediately following the Life Steps 
module of Ziphamandla. However, longer fol-
low-up data were limited as there were missing 
Wisepill data at the 3-month follow up due to 
participants not continuing to charge their 
Wisepill devices. This is an implementation 
Table 1. Demographic information of all 
participants (n = 14).
Variable Mean (SD)
Age (years) 38.4 (7.81)
Highest grade level 9.1 (2.9)
Monthly income 1115.7 (595.9) ZAR
% (n)
Sex
 Female 92.9 (13)
Home language
 isiXhosa 100 (14)
Race/ethnicity
 Xhosa 100 (14)
Work situation
 Unemployed 85.7 (12)
Marital status
 Single 57.1 (8)
 Common law 7.1 (1)
 Widowed 7.1 (1)
 Separated 14.3 (2)
Type of housing
 Shack 64.3 (9)
 House 28.6 (4)
Running water 57.1 (8)
Electricity 92.9 (13)
Cell phone 92.9 (13)
SD: standard deviation.
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challenge that will need to be addressed in 
future studies. Furthermore, although there are 
strengths in using Wisepill, the positive adher-
ence effect of medication monitoring has been 
well established and can only be ruled out with 
the inclusion of a control condition. Future 
studies could benefit from the inclusion of crite-
ria that selects for ART non-adherence, inclu-
sion of biological indicators of adherence, and 
longer follow-up periods. If findings continue 
to replicate, future adaptations to this interven-
tion may consider a greater emphasis on Life 
Steps in the later treatment sessions and may 
also consider adding booster Life Steps 
sessions.
Other implementation challenges were also 
identified that would need to be resolved to 
ensure successful integration of this intervention 
in primary HIV care in South Africa. First, this 
study demonstrates the challenges one may 
encounter when task-sharing CBT via lay coun-
selor delivery, in particular the demands for 
intensive training and supervision. The degree 
of supervision provided in this study could not 
realistically be emulated in a public health clinic 
in South Africa. Potential strategies for decreas-
ing supervision hours need to be considered and 
integrated into future research. Furthermore, 
despite the intensive training and supervision, 
the therapists’ fidelity to intervention delivery 
was low at times, with an average of only 54 per-
cent of generic CBT elements and 63 percent of 
session-specific components being addressed 
across sessions. This highlights the necessity for 
supervisors to review session content on an 
ongoing basis with the therapists in supervision. 
Figure 1. Graphs of estimated means from the generalized mixed models. Note that error bars refer to 
standard errors.
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However, the review of treatment sessions 
would require a further time commitment by the 
supervisors, which potential supervisors in a 
public health clinic may not have. These feasi-
bility issues need to be addressed in future stud-
ies, perhaps using ongoing booster training 
sessions and peer supervision models.
There are a number of limitations to note in 
this study including small sample size and the 
absence of a comparison condition. The almost 
exclusively female sample may limit generaliz-
ability of findings to men. A further potential 
limitation is the slightly different recruitment 
procedure by clinic setting, and any implica-
tions of the differing procedures in recruiting 
the patient population. Also, the effects of the 
intervention on depressive symptoms are larger 
than what would have been expected from a 
six-to-eight session behavioral intervention. It 
is possible that the reliability of this effect is 
limited by the small sample size, and it is also 
difficult to interpret the size of the effect in the 
absence of a randomized, comparison condi-
tion. The reliability of the fidelity ratings may 
have also been biased by the small sample size. 
Furthermore, the reliability and validity of the 
isiXhosa translation of the CES-D could not be 
determined due to the small sample. Participant 
self-reporting of depressive symptoms over 
time may have also been biased by perceived 
investigator expectancy. Nevertheless, despite 
these limitations, the preliminary data promote 
further investigation of the efficacy of the 
Ziphamandla intervention in treating depres-
sion and improving adherence in PLWH in 
South Africa.
Given the resource constraints in primary 
HIV care in South Africa, the identification of an 
acceptable and feasible therapy model that is 
effective in treating depression and improving 
adherence and can be administered by a non-
mental health specialist is imperative for the pro-
vision of mental health care in this population 
(Lund et al., 2010). This study is an important 
first step in adapting CBT techniques for adher-
ence and depression for the South Africa setting 
using a task-sharing approach. Addressing 
depressive symptoms and non-adherence in the 
context of HIV care in South Africa has the 
potential for reducing morbidity and mortality 
and improving secondary HIV prevention. 
Further research addressing the limitations and 
implementation challenges of this study is 
needed to validate and ensure sustainable deliv-
ery of this intervention. A randomized, controlled 
trial of the Ziphamandla intervention in PLWH 
in South Africa, with a cost-effectiveness analy-
sis, is essential.
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Appendix 1
Description of the Ziphamandla 
intervention
Module 1. Psychoeducation and motivational inter-
viewing. The first session of the intervention 
focused on educating patients on depression, 
psychotherapy, and the CBT model, and on 
enhancing patient motivation. Because depres-
sion is not a familiar concept among our popu-
lation and neither is psychotherapy, it was 
important to help patients understand their dis-
order and to provide them with an understand-
ing of the therapeutic process in general and 
CBT specifically.
Module 2. Life Steps. Given the importance of 
ART adherence in PLWH, the second session of 
the treatment was dedicated to the adherence 
intervention called Life Steps. Life Steps con-
sists of 11 educational, cognitive behavioral, 
and problem-solving steps. The goal of the 
intervention is to identify structural and psy-
chological barriers to adherence and problem-
solving ways to overcome these barriers. A 
detailed description of Life Steps can be found 
elsewhere (Safren et al., 2001).
The primary adaptation made to Life Steps 
was the replacement of the suggested plans and 
back-up plans with culturally relevant sugges-
tions. For example, for Life Step 4: Obtaining 
Medications, the suggestion of setting up a medi-
cation mail-in order, which is not possible in 
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South Africa, was replaced with the suggestion 
of having a friend or family member pick up the 
medication at their local clinic on the patient’s 
behalf, which is possible. The order of the steps 
was also changed so they reflected as closely as 
possible the sequence of events that the patients 
follow, that is, transportation to the clinic, obtain-
ing medication (at the clinic), and storing medi-
cation (when they get home from the clinic). 
Two additional steps were added to the Life 
Steps intervention: identifying social supports 
and planning for taking medication when using 
substances. A manual of the adapted Life Steps 
adherence intervention was created and pub-
lished in South Africa (Andersen et al., 2013).
Module 3. Activity scheduling. The primary adapta-
tion of the activity scheduling module was the 
creation of a new activity list. Activities that are 
common in the United States, but are not common 
in South Africa, were replaced by activities that are 
more culturally relevant (e.g. going to church, hav-
ing your hair braided, going to Mzoli’s—a famous 
barbeque joint in the township of Gugulethu).
Module 4. Problem-solving. No adaptations were 
made to the problem-solving module (other 
than the translation of the worksheets into isiX-
hosa). The module consisted of the interven-
tionist and the participant collaboratively 
identifying a problem to work on, creating a 
comprehensive list of possible solutions to the 
problem, deciding on a possible solution for the 
participant to attempt, and breaking the solution 
into manageable steps for the participant to 
complete. The goal of this module was to teach 
the skill of problem-solving across a range of 
problems.
Module 5. Relaxation training. To further sim-
plify and standardize the treatment administra-
tion, a recording was made in isiXhosa of the 
progressive muscle relaxation exercise. This 
allowed the nurses to play the recording after 
demonstrating and rehearsing the diaphrag-
matic breathing technique with the patient. A 
copy of the recording was also provided to each 
patient for use at home.
All the worksheets used in treatment were 
translated into isiXhosa for the benefit of the 
patients. As the Ziphamandla training was con-
ducted in English, the manual remained in 
English; the vocabulary, however, was adjusted 
when needed.
